149 related articles for article (PubMed ID: 10803680)
21. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.
Liu LL; Alaoui-Jamali MA; el Alami N; Castonguay A
Cancer Res; 1990 Mar; 50(6):1810-6. PubMed ID: 2306734
[TBL] [Abstract][Full Text] [Related]
22. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
[TBL] [Abstract][Full Text] [Related]
24. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides.
Smith TJ; Stoner GD; Yang CS
Cancer Res; 1995 Dec; 55(23):5566-73. PubMed ID: 7585636
[TBL] [Abstract][Full Text] [Related]
25. Stereospecific deuterium substitution attenuates the tumorigenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Jalas JR; McIntee EJ; Kenney PM; Upadhyaya P; Peterson LA; Hecht SS
Chem Res Toxicol; 2003 Jun; 16(6):794-806. PubMed ID: 12807363
[TBL] [Abstract][Full Text] [Related]
26. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
27. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
Chiang HC; Wang CY; Lee HL; Tsou TC
Toxicol Appl Pharmacol; 2011 Jun; 253(2):145-52. PubMed ID: 21473878
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells.
Schrader E; Hirsch-Ernst KI; Scholz E; Kahl GF; Foth H
Drug Metab Dispos; 2000 Feb; 28(2):180-5. PubMed ID: 10640516
[TBL] [Abstract][Full Text] [Related]
29. CYP2D6 genotype and the incidence of anal and vulvar cancer.
Chen C; Cook LS; Li XY; Hallagan S; Madeleine MM; Daling JR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):317-21. PubMed ID: 10207635
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic.
Yang CS; Chhabra SK; Hong JY; Smith TJ
J Nutr; 2001 Mar; 131(3s):1041S-5S. PubMed ID: 11238812
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6.
Penman BW; Reece J; Smith T; Yang CS; Gelboin HV; Gonzalez FJ; Crespi CL
Pharmacogenetics; 1993 Feb; 3(1):28-39. PubMed ID: 8485585
[TBL] [Abstract][Full Text] [Related]
32. Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster.
Rossignol G; Alaoui-Jamali MA; Castonguay A; Schuller HM
Cancer Res; 1989 Oct; 49(20):5671-6. PubMed ID: 2790785
[TBL] [Abstract][Full Text] [Related]
33. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.
Tsukino H; Kuroda Y; Qiu D; Nakao H; Imai H; Katoh T
Int J Cancer; 2002 Aug; 100(4):425-8. PubMed ID: 12115524
[TBL] [Abstract][Full Text] [Related]
34. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.
Anwar WA; Abdel-Rahman SZ; El-Zein RA; Mostafa HM; Au WW
Carcinogenesis; 1996 Sep; 17(9):1923-9. PubMed ID: 8824515
[TBL] [Abstract][Full Text] [Related]
36. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
37. The application of hepatic P450 reductase null gpt delta mice in studying the role of hepatic P450 in genotoxic carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mutagenesis.
Luan Y; Xing G; Qi X; Wu M; Li C; Yao J; Gong L; Nohmi T; Gu J; Zhou W; Zheng S; Ren J
Arch Toxicol; 2012 Nov; 86(11):1753-61. PubMed ID: 22710403
[TBL] [Abstract][Full Text] [Related]
38. The effect of a 2-h exposure to cigarette smoke on the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Brown BG; Richter E; Tricker AR; Ayres PH; Doolittle DJ
Chem Biol Interact; 2001 Nov; 138(2):125-35. PubMed ID: 11672696
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity.
Karamanakos PN; Trafalis DT; Geromichalos GD; Pappas P; Harkitis P; Konstandi M; Marselos M
Arch Toxicol; 2009 Jun; 83(6):571-80. PubMed ID: 18754103
[TBL] [Abstract][Full Text] [Related]
40. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Environ Mol Mutagen; 2001; 38(4):339-46. PubMed ID: 11774366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
